These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6109531)

  • 1. The use of thioproperazine, a phenothiazine derivative, as a ligand for neuroleptic receptors--I. In vitro studies.
    Blanchard JC; Boireau A; Garret C; Julou L
    Biochem Pharmacol; 1980 Nov; 29(21):2933-8. PubMed ID: 6109531
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of thioproperazine, a phenothiazine derivative, as a ligand for neuroleptic receptors--II. In vivo studies.
    Boireau A; Blanchard JC; Garret C; Julou L
    Biochem Pharmacol; 1980 Nov; 29(21):2939-42. PubMed ID: 6109532
    [No Abstract]   [Full Text] [Related]  

  • 3. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

  • 4. Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.
    Leysen JE; Gommeren W; Laduron PM
    Biochem Pharmacol; 1978 Feb; 27(3):307-16. PubMed ID: 23126
    [No Abstract]   [Full Text] [Related]  

  • 5. LSD as an agonist and antagonist at central dopamine receptors.
    Von Hungen K; Roberts S; Hill DF
    Nature; 1974 Dec; 252(5484):588-9. PubMed ID: 4431522
    [No Abstract]   [Full Text] [Related]  

  • 6. Solubilization and characterization of [3H]spiroperidol binding sites from subcellular fractions of the calf striatum.
    Clement-Cormier YC; Kendrick PE
    Biochem Pharmacol; 1980 Mar; 29(6):897-903. PubMed ID: 7387707
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution of stereospecific opiate receptor binding activity between subcellular fractions from ovine corpus striatum.
    Glasel JA; Venn RF; Barnard EA
    Biochem Biophys Res Commun; 1980 Jul; 95(1):263-8. PubMed ID: 6251804
    [No Abstract]   [Full Text] [Related]  

  • 8. Spiperone: a ligand of choice for neuroleptic receptors. 3. Subcellular distribution of neuroleptic drugs and their receptors in various rat brain areas.
    Laduron PM; Janssen PF; Leysen JE
    Biochem Pharmacol; 1978 Feb; 27(3):323-8. PubMed ID: 23128
    [No Abstract]   [Full Text] [Related]  

  • 9. The accumulation of dopamine into striatal synaptosomes, and its inhibition: comparison of crude, partially purified and purified synaptosomal preparations.
    Tuomisto J; Tuomisto L
    Med Biol; 1979 Aug; 57(4):238-45. PubMed ID: 513880
    [No Abstract]   [Full Text] [Related]  

  • 10. [The biochemical effects of a new antidepressive, metapramine (RP 19560) on activity of the dopaminergic and cholinergic systems of the rat striatum].
    Boireau A; Garret C; Blanchard JC
    J Pharmacol; 1986; 17(1):75-84. PubMed ID: 2872367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA; Bennett JP
    Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats.
    De Blasi A; Mennini T
    Brain Res; 1982 Jun; 242(2):361-4. PubMed ID: 7116143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene): a prototype for possible dopaminergic false transmitters?
    Roberts PJ; Davis A
    Adv Biochem Psychopharmacol; 1978; 19():177-91. PubMed ID: 696460
    [No Abstract]   [Full Text] [Related]  

  • 14. Unitary dopaminergic receptor composed of cooperatively linked agonist and antagonist sub-unit binding sites.
    Leysen JE
    Commun Psychopharmacol; 1979; 3(6):397-410. PubMed ID: 546588
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of the relative hydrophobicity and interaction with striatal dopamine receptors in the bull of representative dialkylaminoalkyl and dialkylaminoacyl phenothiazine derivatives].
    Brusova EG; Savel'eva MV
    Biull Eksp Biol Med; 1988 Aug; 106(8):163-5. PubMed ID: 2901277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of a conformationally restricted dopamine analogue, 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, to receptors on rat brain synaptic membranes.
    Roberts PJ; Woodruff GN; Poat JA
    Mol Pharmacol; 1977 May; 13(3):541-7. PubMed ID: 17829
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine receptor binding in the corpus striatum of mammalian brain.
    Burt DR; Enna SJ; Creese I; Snyder SH
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4655-9. PubMed ID: 1060143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine/neuroleptic receptors in basal hypothalamus and pituitary.
    Brown GM; Seeman P; Lee T
    Endocrinology; 1976 Nov; 99(5):1407-6. PubMed ID: 991828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differences in the efficiency of their interaction with membrane receptors of the dialkylaminoalkyl and dialkylaminoacyl derivatives of phenothiazine].
    Savel'eva MV; Ratner EI; Baldenko GN; Kaverina NV
    Biull Eksp Biol Med; 1990 Mar; 109(3):266-8. PubMed ID: 1973058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.
    Cannon JG; Costall B; Laduron PM; Leysen JE; Naylor RJ
    Biochem Pharmacol; 1978 May; 27(10):1417-20. PubMed ID: 567987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.